Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India |
Varghese, Jophy
(Department of Pathology, Lourdes Hospital)
Kuruvilla, Priya Mariam (Department of Pathology, Lourdes Hospital) Mehta, Nisarg (Department of Urology, Lourdes Hospital) Rathore, Ranjeet Singh (Department of Urology, Lourdes Hospital) Babu, Manas (Department of Urology, Lourdes Hospital) Bansal, Devesh (Department of Urology, Lourdes Hospital) Pillai, Biju (Department of Urology, Lourdes Hospital) Sam, Mohan P (Department of Urology, Lourdes Hospital) Krishnamorthy, H (Department of Urology, Lourdes Hospital) |
1 | Zigeuner RE, Lipsky K, Riedler I et al (2003). Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urol, 624, 451-5. |
2 | Baade PD, Yu XQ, Smith DP, et al (2015). Geographic disparities in prostate cancer outcomes - review of international patterns. Asian Pac J Cancer Prev, 16, 1259-75. DOI |
3 | Bashir NM (2015). Epidemiology of prostate cancer. Asian Pac J Cancer Prev, 16, 5137-41. DOI |
4 | Catalona WJ, Richie JP, Ahmann FR, et al (1994). Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 151, 1283-90. DOI |
5 | Edge SB, Byrd DR, Compton CC, et al (2010). (Eds.) American joint committee on cancer (AJCC). Cancer staging manual. 7th edition. Springer, New York, NY. |
6 | Epstein JI, Allsbrook WC Jr, Amin MB, et al (2005). ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol, 29, 1228-42. DOI |
7 | Esfahani M, Ataei N, Panjehpour M (2015). Biomarkers for evaluation of prostate cancer prognosis. Asian Pac J Cancer Prev, 16, 2601-11. DOI |
8 | Fowler JE Jr, Pandey P, Bigler SA, et al (1997). Trends in diagnosis of stage T1a-b prostate cancer. J Urol, 158, 1849-52. DOI |
9 | Jones JS, Follis HW, Johnson JR (2009). Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis; 12, 57-60. DOI |
10 | Kash DP, Lal M, Hashmi AH, et al (2014). Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective. Asian Pac J Cancer Prev, 15, 3087-91. DOI |
11 | Melchior S, Hadaschik B, Thuroff S, et al (2008). Outcome of radical prostatectomy for incidental carcinoma of the prostate. BJU International, 103, 1478-81. |
12 | Oesterling JE, Jacobsen SJ, Chute CG et al (1993). Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA, 270, 860-4. DOI |
13 | Saleh AM, Fooladi MM, Nustas WP, et al (2015). Enhancing knowledge, beliefs, and intention to screen for prostate cancer via different health educational interventions: a literature review. Asian Pac J Cancer Prev, 16, 5137-41. DOI |
14 | Tombal B, De Visccher L, Cosyns JP, et al (1999). Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers, BJU International, 84, 1015-20. |
15 | Yoo C, Oh CY, Kim SJ, et al (2012). Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissueablative surgery for benign prostatic hyperplasia: A Korean multi-center review. Korean J Urol, 53, 391-5. DOI |